| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment: A multicenter, randomized phase II trial
|
Pu, Xingxiang
|
|
|
191 |
C |
p.
|
artikel
|
| 2 |
A pragmatic guide for management of adverse events associated with lorlatinib
|
Liu, Geoffrey
|
|
|
191 |
C |
p.
|
artikel
|
| 3 |
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia
|
Okahisa, Masanobu
|
|
|
191 |
C |
p.
|
artikel
|
| 4 |
Clinical significance of inter-assay discrepancy in PD-L1 evaluation for the efficacy of pembrolizumab in advanced NSCLC with high PD-L1 expression
|
Miyakoshi, Jun
|
|
|
191 |
C |
p.
|
artikel
|
| 5 |
Contents
|
|
|
|
191 |
C |
p.
|
artikel
|
| 6 |
Establishing mesothelioma patient-derived organoid models from malignant pleural effusions
|
Hocking, Ashleigh J.
|
|
|
191 |
C |
p.
|
artikel
|
| 7 |
Familial rare EGFR-mutant lung cancer syndrome: Review of literature and description of R776H family
|
Gabriel, L.
|
|
|
191 |
C |
p.
|
artikel
|
| 8 |
Identification of a novel ALK inhibitor-sensitive PRKCE-ALK gene fusion in lung adenocarcinoma
|
Wang, Lan
|
|
|
191 |
C |
p.
|
artikel
|
| 9 |
Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysis
|
Zhang, Shu-Ling
|
|
|
191 |
C |
p.
|
artikel
|
| 10 |
Is the onset of immune-related adverse events themselves a prognostic factor or a confounding factor?
|
Nishimura, Tadashi
|
|
|
191 |
C |
p.
|
artikel
|
| 11 |
Long-term follow-up and exploratory analysis of lenvatinib in patients with metastatic or recurrent thymic carcinoma: Results from the multicenter, phase 2 REMORA trial
|
Niho, Seiji
|
|
|
191 |
C |
p.
|
artikel
|
| 12 |
Lung cancer among the Elderly in Denmark – A comprehensive population-based cohort study
|
Lyhne Christensen, Niels
|
|
|
191 |
C |
p.
|
artikel
|
| 13 |
Management of sotorasib-related adverse events and hepatotoxicities following anti-PD-(L)1 therapy: Experience with sotorasib in two French anti-cancer centers and practical guidance proposal
|
Chour, Ali
|
|
|
191 |
C |
p.
|
artikel
|
| 14 |
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer
|
Tozuka, Takehiro
|
|
|
191 |
C |
p.
|
artikel
|
| 15 |
Proteomic profiling of tumor microenvironment and prognosis risk prediction in stage I lung adenocarcinoma
|
Lu, Yueh-Feng
|
|
|
191 |
C |
p.
|
artikel
|
| 16 |
Revisiting the lung cancer screening eligibility criteria to promote equity for Black individuals
|
Gudina, Abdi T.
|
|
|
191 |
C |
p.
|
artikel
|
| 17 |
Spatiotemporal distribution of mediastinal neoplasms: A comprehensive multi-center study
|
Jiang, Yu
|
|
|
191 |
C |
p.
|
artikel
|
| 18 |
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database
|
Malapelle, Umberto
|
|
|
191 |
C |
p.
|
artikel
|
| 19 |
The cost-effectiveness of including liquid biopsy into molecular profiling strategies for newly diagnosed advanced non-squamous non-small cell lung cancer in an Asian population
|
Liu, Sibo
|
|
|
191 |
C |
p.
|
artikel
|
| 20 |
The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy – a nationwide cohort study
|
de Ruiter, Julianne Cynthia
|
|
|
191 |
C |
p.
|
artikel
|
| 21 |
Trends and predictors of Quality of Life in lung cancer survivors
|
Bade, Brett C
|
|
|
191 |
C |
p.
|
artikel
|
Tijdschrift beschrijving